$PBAXU News
Last published 4y ago
- 4y agoPBAXUPhoenix Biotech Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on November 26, 2021GlobeNewswireOakland, CA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU) (the "Company"), a blank-check company formed for the purpose of acquiring or merging with one or more businesses, today announced that the holders of the C
- 5y agoAFFYBOLTETNBPBAXU+389bio Announces Appointment of Kathy LaPorte to its Board of DirectorsGlobeNewswireSAN FRANCISCO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- 89bio, Inc. (NASDAQ:ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, to
- 5y agoPBAXPBAXUPhoenix Biotech Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment OptionGlobeNewswireOakland, CA, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU) (the "Company"), a blank-check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or si
- 5y agoPBAXUPhoenix Biotech Acquisition Corp. Announces Pricing of $155,000,000 Initial Public OfferingGlobeNewswireOakland, CA, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU) (the "Company"), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or si